Summary

This AI-generated content is provided without warranty, with no liability accepted for reliance on it. Learn more.

• Lactitol (Pizensy) is indicated for the treatment of chronic idiopathic constipation (CIC) in adults, especially within the elderly population.
• The efficacy and safety of laxatives in treating constipation among patients over 65 years old were evaluated in one systematic review/meta-analysis.
• This evaluation included 23 randomized controlled trials comparing various types of laxatives to placebos or other similar drugs.
• In terms of efficacy, lactitol, along with several other laxatives, showed greater effectiveness than placebos for short-term use in elderly patients suffering from constipation. However, long-term safety and efficacy data specifically for lactitol were not provided, except for Polyethylene Glycol, which was highlighted as safe and effective for around six months of usage.
• Regarding safety considerations, adverse effects reported did not differ significantly between treatment groups, suggesting a similar frequency and severity across different laxative treatments, including Pizensy (Lactitol).
• It is important to note that these findings are based strictly on the studied material; additional comprehensive data could further refine these conclusions, especially concerning direct comparisons between Lactitol (Pizensy) and other laxatives, particularly regarding long-term use within specific subpopulations such as older adults.